Table of Contents
- General Information
- Vaccine Related Pathogen Genes
- 7299
- AAV2gp02 (Adeno-associated virus - 2)
- ABALON (Homo sapiens)
- ABL2 (Homo sapiens)
- ACP3 (Homo sapiens)
- ACPP (Homo sapiens)
- ADAM17 (Homo sapiens)
- AFP (Homo sapiens)
- AFP from human-Obsolete (Homo sapiens)
- ag85A (Mycobacterium tuberculosis H37Rv)
- AIM2 (Homo sapiens)
- AKAP4 (Homo sapiens)
- AKT1 (Homo sapiens)
- ALDH1A1 (Homo sapiens)
- ALDH2 (Homo sapiens)
- ANTXR1 (Homo sapiens)
- AR (Homo sapiens)
- asdfaf asf
- ASTE1 (Homo sapiens)
- ATL1 (Homo sapiens)
- B4GALNT1 (Homo sapiens)
- BCAP31 (Homo sapiens)
- BCL2L1 (Homo sapiens)
- CA9 (Homo sapiens)
- CCL21 (Homo sapiens)
- Ccl21a (Mus musculus)
- CCNG1 (Homo sapiens)
- CCNI (Homo sapiens)
- CCR5 (Homo sapiens)
- CCR7 (Homo sapiens)
- CD19 (Homo sapiens)
- CD1D (Homo sapiens)
- CD22 (Homo sapiens)
- CD33 (Homo sapiens)
- CD38 (Homo sapiens)
- CD3D (Homo sapiens)
- CD40 (Homo sapiens)
- Cd40lg (Mus musculus)
- CD40LG (Homo sapiens)
- CD44 (Homo sapiens)
- CD55 (Homo sapiens)
- CD58 (Homo sapiens)
- CD70 (Homo sapiens)
- Cd80 (Mus musculus)
- CD80 (Homo sapiens)
- Cd86 (Mus musculus)
- CD86 (Homo sapiens)
- CD8A (Homo sapiens)
- CD90 (Homo sapiens)
- CDH3 (Homo sapiens)
- CDK1 (Homo sapiens)
- cdsR (Chlamydia trachomatis A/HAR-13)
- Cea-Mouse (Mus musculus)
- CEACAM1 (Homo sapiens)
- CEACAM3 (Homo sapiens)
- CEACAM5 (CEA) (Homo sapiens)
- CEACAM5 - obsolete (Homo sapiens)
- CHI3L1 (Homo sapiens)
- CLEC3B (Homo sapiens)
- CLEC4C (Homo sapiens)
- CRY2 (Arabidopsis thaliana)
- CSF1R (Homo sapiens)
- Csf2-Mouse (Mus musculus)
- CSH1 (Homo sapiens)
- CTAG1B (Homo sapiens)
- CTAG2 (Homo sapiens)
- CTLA4 (Homo sapiens)
- cupB5 (Pseudomonas aeruginosa PAO1)
- CYP1B1 (Homo sapiens)
- DCT (Homo sapiens)
- DCT (Homo sapiens)
- DDR1 (Homo sapiens)
- DEPDC1 (Homo sapiens)
- DItox
- E1B (Human mastadenovirus C)
- E2A (Mus musculus)
- E6 (Human papillomavirus type 16)
- E7 (Human papillomavirus type 16)
- EBNA-1 (Human gammaherpesvirus 4)
- EGFR (Homo sapiens)
- Emb (Mus musculus)
- Eng (Mus musculus)
- ENG (Homo sapiens)
- env (Human immunodeficiency virus 1)
- EPCAM (Homo sapiens)
- EPHA2 (Homo sapiens)
- ERBB2 (Homo sapiens)
- Erbb2 (Rattus norvegicus)
- EWSR1 (Homo sapiens)
- Fasl (Mus musculus)
- FASLG (Homo sapiens)
- FCY1 (Saccharomyces cerevisiae S288C)
- FGF2 (Homo sapiens)
- FGF5 (Homo sapiens)
- FIM3 (Homo sapiens)
- FL1 (Homo sapiens)
- FLT1 (Homo sapiens)
- Flt3 (Mus musculus)
- FLT3LG (Homo sapiens)
- FOLH1 (Homo sapiens)
- FOLR1 (Homo sapiens)
- Fosl1 (Mus musculus)
- FOXO1 (Homo sapiens)
- Fragment C from tetanus toxin (Clostridium tetani)
- FUS (Homo sapiens)
- GAA (Homo sapiens)
- GALC (Homo sapiens)
- Gla (Mus musculus)
- GLIPR1 (Homo sapiens)
- GM-CSF (Papio anubis)
- GM-CSF (human) (Homo sapiens)
- GM-CSF (Mus musculus) (Mus musculus)
- GM2A (Homo sapiens)
- GNRH1 (Homo sapiens)
- Gnrh1 (Mus musculus)
- gp100 (PMEL) (Homo sapiens)
- gp160
- gp72 (Human herpesvirus 4 type 2)
- GPC3 (Homo sapiens)
- GPR183 (Homo sapiens)
- GPT (Homo sapiens)
- GRDX (Homo sapiens)
- GRIN1 (Homo sapiens)
- GRP (Homo sapiens)
- GUCY2C (Homo sapiens)
- H2-K1 (Mus musculus)
- HA (Influenza A virus (A/California/07/2009(H1N1)))
- HBB (Homo sapiens)
- HBsAg (Hepatitis B virus)
- HER2-Dupli
- HLA-A (Homo sapiens)
- HLA-B (Homo sapiens)
- HLA-DRB1 (Homo sapiens)
- HPV6 E6 (Human papillomavirus type 6)
- HPV6 E6 (Human papillomavirus type 6)
- HRAS (Homo sapiens)
- HSP47 (Mus musculus)
- HSP90B1 (Homo sapiens)
- HSPA4 (Homo sapiens)
- HSPD1 (Homo sapiens)
- HuD (Homo sapiens)
- human TP53 (P53) (Homo sapiens)
- HUMGP 75 (Homo sapiens)
- ICAM1 (Homo sapiens)
- ID1 (Homo sapiens)
- IDH1 (Homo sapiens)
- IDO1 (Homo sapiens)
- IFNA2 (Homo sapiens)
- IFNB1 (Homo sapiens)
- IFNG (Homo sapiens)
- IFNG- Obsolete (Homo sapiens)
- IFNL3 (Homo sapiens)
- IGF2BP3 (Homo sapiens)
- IGFBP1 (Homo sapiens)
- IgG Fc (Homo sapiens)
- IGHG1 (Homo sapiens)
- IL12 (Sus scrofa)
- IL12A (Homo sapiens)
- IL12B (Homo sapiens)
- IL13RA2 (Homo sapiens)
- Il18 (Mus musculus)
- IL2 (Homo sapiens)
- IL2-Duplicate (Homo sapiens)
- IL24 (Homo sapiens)
- IL3RA (Homo sapiens)
- Immunoglobulin (Homo sapiens)
- ITGB8 (Homo sapiens)
- ITIH4 (Homo sapiens)
- JUP (Homo sapiens)
- KDR (Homo sapiens)
- Kdr (Mus musculus)
- KIF20B (Homo sapiens)
- KLK3 (Homo sapiens)
- KLK3-Dupli (Homo sapiens)
- KRAS (Homo sapiens)
- KRAS (Homo sapiens)
- L1 (Human papillomavirus)
- lacZ (Escherichia coli str. K-12 substr. MG1655)
- LADD-Ag
- LILRA2 (Homo sapiens)
- LMP-1 (Human gammaherpesvirus 4)
- LMP-2A (Human gammaherpesvirus 4)
- LV28_RS26095 transcriptional regulator RegF (Pandoraea pnomenusa)
- LY6K (Homo sapiens)
- MAGE-1 (Homo sapiens)
- MAGEA1 (MAGE1) (Homo sapiens)
- MAGEA1-Duplicate
- MAGEA10 (Homo sapiens)
- MAGEA2 (Homo sapiens)
- MAGEA3 (Homo sapiens)
- MAGEA6 (Homo sapiens)
- MAGEA9 (Homo sapiens)
- MAGEC1 (Homo sapiens)
- MAGEC2 (Homo sapiens)
- major capsid protein L1
- MBL2 (Homo sapiens)
- Mcam (Mus musculus)
- MDM2 (Homo sapiens)
- MFGE8 (Homo sapiens)
- MGMT (Homo sapiens)
- Mice Gene
- MLANA (Homo sapiens)
- MLANA-Dupli (Homo sapiens)
- mouse Trp53 (Mus musculus)
- MOV10 (Homo sapiens)
- MS4A1 (Homo sapiens)
- MSLN (Homo sapiens)
- MUC1 (Homo sapiens)
- Muc1 (Mus musculus)
- MUC16 (Homo sapiens)
- MUC2 (Homo sapiens)
- MUC5B (Homo sapiens)
- NF2 (Homo sapiens)
- NRAS (Homo sapiens)
- NRP1 (Homo sapiens)
- NSCLC
- NUF2 (Homo sapiens)
- NY-ESO-1 (Homo sapiens)
- ny-eso-1
- ORF68 (Human alphaherpesvirus 3)
- P10
- PAEP (Homo sapiens)
- PAGR1 (Homo sapiens)
- PAP (Mus musculus)
- Pap antigen (Homo sapiens)
- PAX3 (Homo sapiens)
- PDCD1 (Homo sapiens)
- Pdgfrb (Mus musculus)
- PMEL - OBSOLETE (Homo sapiens)
- PMEL - obsolete (Homo sapiens)
- Pmel17 (Mus musculus)
- pp65 (Mus musculus)
- PRAME (Homo sapiens)
- Prn (Mus musculus)
- PROM1 (Homo sapiens)
- Prostate specific antigen (Mus musculus)
- Prostate stem cell antigen (Mus musculus)
- Prostate-specific membrane antigen (Homo sapiens)
- Prostate-specific membrane antigen (Rattus norvegicus)
- PSMB9 (Homo sapiens)
- PTPRC (Homo sapiens)
- PTTG1 (Homo sapiens)
- RANBP2 (Homo sapiens)
- RHD (Homo sapiens)
- RNF43 (Homo sapiens)
- ROPN1 (Homo sapiens)
- Rpsa (Mus musculus)
- RUNX1 (Homo sapiens)
- S (Hepatitis B virus)
- S100A6 (Homo sapiens)
- S100A9 (Homo sapiens)
- SCFV (Homo sapiens)
- SCGB2A2 (Homo sapiens)
- SDC1 (Homo sapiens)
- SDC1-Obsolete (Homo sapiens)
- sialyl-Tn
- SILV (Homo sapiens)
- SLAMF7 (Homo sapiens)
- SLC5A5 (Homo sapiens)
- SOX2 (Homo sapiens)
- SOX6 (Homo sapiens)
- SPA17 (Homo sapiens)
- SPANXB1 (Homo sapiens)
- SPBC17D11.03c hypothetical protein (Schizosaccharomyces pombe)
- SPY-1
- ST8SIA1 (Homo sapiens)
- Steap1 (Mus musculus)
- STEAP1 (Homo sapiens)
- Survivin (Homo sapiens)
- Survivin (Mus musculus)
- TAF1B (Homo sapiens)
- TARP (Homo sapiens)
- TBXT (Homo sapiens)
- TERT (Homo sapiens)
- TET1 (Homo sapiens)
- tetX (Clostridium tetani E88)
- TF (Homo sapiens)
- TGFB2 (Homo sapiens)
- Th (Mus musculus)
- TLR4 (Homo sapiens)
- TLR7 (Homo sapiens)
- TLR9 (Homo sapiens)
- TMEM37 (Homo sapiens)
- TNF (Homo sapiens)
- tnf-alpha (Oncorhynchus mykiss)
- TNFRSF18 (Homo sapiens)
- TNFSF10 (Homo sapiens)
- TNFSF18 (Homo sapiens)
- TOMM34 (Homo sapiens)
- TOP2A (Homo sapiens)
- tox1 (Corynebacterium diphtheriae PW8)
- TP53 - delete (Homo sapiens)
- TPBG (Homo sapiens)
- TRP-1 (Mus musculus)
- TRP-2 (Homo sapiens)
- Trp2 (Mus musculus)
- TRPC1 (Homo sapiens)
- Tumor Associated Antigen
- Tyrosinase (Homo sapiens)
- Tyrosinase from Mouse (Mus musculus)
- TYRP1 (Homo sapiens)
- Tyrp1 (Mus musculus)
- Ubiquitin (Mus musculus)
- UL122 (Human betaherpesvirus 5)
- UL123 (Human betaherpesvirus 5)
- UL83 (Human betaherpesvirus 5)
- UL83 (Human betaherpesvirus 5)
- UL97
- VEGFA (Homo sapiens)
- VHL (Homo sapiens)
- WHcAg (Woodchuck hepatitis virus)
- WT1 (Homo sapiens)
- Xbp1 (Mus musculus)
- XBP1 (Homo sapiens)
- Xcl1 (Mus musculus)
- XCL1 (Homo sapiens)
- YBX1 (Homo sapiens)
- Vaccine Information
- (H115D)VHL35 Peptide Vaccine
- 1(SOCS1)-silenced dentritic cell (DC) vaccines
- 117-126:FGF-5 Peptide
- 12MP
- 12MP, 12MP/Tet, 12MP/6MHP, or 6MHP
- 27-35(27L):MART-1 peptide vaccine
- 4-peptide melanoma vaccine
- 851B Gel
- A2/4-1BBL melanoma vaccine
- Abagovomab
- Ad CMV I kappaB alpha
- Ad-sig-hMUC-1/ecdCD40L Vaccine
- Ad5-yCD/mutTKSR39rep-hIL12
- Ad5F35-LMP1/LMP2-Transduced Autologous Dendritic Cells
- Adenovector Encoding MDA7
- Adenovector-transduced AP1903-inducible MyD88/CD40-expressing Autologous PSMA-specific Prostate Cancer Vaccine BPX-201
- Adenoviral Vector Ad5-CEA(6D) Vaccine
- Adenovirus 5-CD40 Ligand
- Adenovirus 5-Fibroblast Growth Factor 2
- Adenovirus 5-Human Guanylyl Cyclase C-PADRE Vaccine
- Adenovirus B7-1
- Adenovirus Encoding Rat HER-2/neu
- Adenovirus Encoding Tyrosinase/MART-1/MAGEA6-transduced Autologous Dendritic Cell Vaccine
- Adenovirus HER2-Transduced Autologous Dendritic Cell Vaccine
- Adenovirus RSV-TK
- Adenovirus-mediated Human Interleukin-12
- Adenovirus-p53 Transduced Dendritic Cell Vaccine
- Adenovirus-PSA Prostate Cancer Vaccine
- adenovirus-transfected autologous DC vaccine plus CIK cells
- Adenovirus-vectored therapeutic vaccine (Ad-Ii-E1E2E6E7)
- AdRTVP-1-Transduced Prostate Cancer Cell-Based Vaccine
- AE37 Peptide/GM-CSF Vaccine
- AFP Gene Hepatocellular Carcinoma Vaccine
- Ag NY-ESO-1
- AGS-003-BLD Vaccine
- AIM2(-1)/HT001(-1)/TAF1B(-1) Frameshift Peptide Vaccine
- Algenpantucel-L
- ALK peptide vaccine
- Allogeneic AML Antigen-expressing Dendritic Cell Vaccine
- Allogeneic B7.1/HLA-A1 Transfected Tumor Cell Vaccine
- Allogeneic Cellular Vaccine 1650-G
- Allogeneic Dendritic Cell Vaccine COMBIG-DC
- Allogeneic Dendritic Cell-Myeloma Idiotype Vaccine
- Allogeneic Glioblastoma Stem-like Cell Line Lysate-pulsed Autologous Dendritic Cell Vaccine
- Allogeneic GM-CSF-Based Myeloma Cell Vaccine
- Allogeneic GM-CSF-Secreting Breast Cancer Vaccine
- Allogeneic GM-CSF-secreting Lethally Irradiated Pancreatic Tumor Cell Vaccine
- Allogeneic GM-CSF-secreting Tumor Vaccine PANC 10.05 pcDNA-1/GM-Neo
- Allogeneic GM-CSF-secreting Tumor Vaccine PANC 6.03 pcDNA-1/GM-Neo
- Allogeneic HLA-A2/4-1BB ligand-expressing Melanoma Vaccine
- Allogeneic Large Multivalent Immunogen Breast Cancer Vaccine
- Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307
- Allogeneic Melanoma Vaccine AGI-101H
- Allogeneic Mesothelioma Tumor Lysate-pulsed Autologous Dendritic Cell Vaccine
- Allogeneic Multipotent Adult Progenitor Cells
- Allogeneic Renal Cell Carcinoma Vaccine MGN1601
- Allogeneic Tumor Cell Vaccine
- Allogenic Glioma Cancer Vaccine
- Alpha Fetoprotein Adenoviral Vector Vaccine
- Alpha Fetoprotein Plasmid DNA Vaccine
- Alpha-1,3-galactosyltransferase-expressing Allogeneic Renal Cell Carcinoma Vaccine
- Alpha-fetoprotein Peptide-Pulsed Autologous Dendritic Cell Vaccine
- Alpha-Galactosylceramide-Pulsed Autologous Dendritic Cells
- Alpha-type-1 Polarized Dendritic Cells
- ALVAC gp100 Vaccine
- ALVAC Vaccine
- ALVAC(2) Melanoma Multi-antigen Vaccine
- ALVAC(2)-NY-ESO-1 (M)/TRICOM Vaccine
- ALVAC-B7-CEA
- ALVAC-CEA (6D)-B7.1 Vaccine
- ALVAC-CEA (VCP248)
- ALVAC-CEA B7.1 Vaccine
- ALVAC-CEA Vaccine
- ALVAC-ESO-1 Vaccine
- ALVAC-hB7.1
- ALVAC-MART-1 Vaccine
- ALVAC-P53 Vaccine
- AMHR2-ED
- AML mRNA Positive Lysate Loaded Autologous Dendritic Cell Vaccine
- Amolimogene Bepiplasmid
- Androgen Receptor Ligand-binding Domain-encoding Plasmid DNA Vaccine MVI-118
- Ankara (MVA) and ALVAC(2) Vaccine
- Ankara (MVA) Vaccine
- Anti-CD19/CD3 Tetravalent Antibody AFM11 Vaccine
- Anti-CD3 x Anti-CD20 Bispecific Antibody-Armed Activated T Cells Cancer Vaccine
- Anti-CEA TCR Retroviral Vector-Transduced Autologous Peripheral Blood Lymphocytes
- Anti-CTLA4 MoAb RNA-transfected Autologous Dendritic Cell Vaccine
- Anti-CTLA4 MoAb RNA/GITRL RNA-transfected Autologous Dendritic Cell Vaccine
- Anti-GnRH Vaccine PEP223
- Anti-HER2/HER3 Dendritic Cell Vaccine
- Anti-idiotype MUC-1 Monoclonal Antibody Vaccine
- Anti-Idiotype Specified Monoclonal Antibody
- anti-idiotypic (anti-id) mAb MK2-23 + BCG
- Anti-idiotypic Monoclonal Antibody BEC2 Vaccine
- Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A
- Anti-NY-ESO1 TCR-transduced Autologous CD62L+-derived T-Lymphocytes
- Anti-p53 T-Cell Receptor-Transduced Peripheral Blood Lymphocytes Vaccine
- Anti-PRAME Immunotherapeutic GSK2302032A Vaccine
- Antigen-CPP vaccine
- Antigen-targeted Personalized Breast Cancer Vaccine
- APC8015F
- Apoptotic Autologous Tumor Cells-pulsed Alpha-type-1 Polarized Dendritic Cells
- attenuated Listeria expressing cancer antigen vaccine
- AUT-OV-ALVAC-hB7.1 Vaccine
- Autolgous DC Vaccine Pulsed with Autologous Tumor Homogenate for Metastatic RCC
- Autologous Ad-CD154-Transduced CLL B Cells
- Autologous Anti-gp100:154-162 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes
- Autologous Anti-MART-1 F5 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes
- Autologous Cancer Testis Antigen Specific Dendritic Cell Vaccine
- Autologous CD133-Positive BTSC mRNA-Pulsed Autologous Dendritic Cell Vaccine
- Autologous CD40L-expressing B-CLL Vaccine
- Autologous CLL Tumor Cell Vaccine
- Autologous CMV-pp65-flLAMP mRNA Loaded Dendritic Cell Vaccine
- Autologous Colorectal Tumor Antigen-pulsed Dendritic Cell Vaccine
- Autologous CT7/MAGE-A3/WT1 mRNA-Electroporated Langerhans-Type Dendritic Cells
- autologous dendritic cell vaccine (DCV)
- Autologous Dendritic Cell Vaccine ACT2001
- Autologous dendritic cell vaccine loaded with personalized peptides (PEP-DC vaccine)
- Autologous Dendritic Cell-Adenovirus CCL21 Vaccine
- Autologous Dendritic Cell-Adenovirus P53 Vaccine
- Autologous Dendritic Cell-Allogeneic Melanoma Tumor Cell Lysate Vaccine
- Autologous Dendritic Cell-Autologous Tumor mRNA-Human CD40L Vaccine
- Autologous Dendritic Cell-based Immunotherapeutic AV0113
- Autologous Dendritic Cell-Tumor Fusion Vaccine
- autologous dendritic cells (DCs)
- Autologous Dinitrophenyl Vaccine
- Autologous Dinitrophenyl-Modified Ovarian Cancer Vaccine
- Autologous EBV-Transformed B Lymphoblastoid-Tumor Fusion Cell Vaccine
- Autologous Epstein-Barr Virus-Transformed B-Lymphoblastoid Cell Vaccine
- Autologous Expanded Mesenchymal Stem Cells OTI-010
- Autologous GM-CSF-Secreting Breast Cancer Vaccine
- Autologous GM-CSF-secreting Lethally Irradiated Colorectal Cancer Cell Vaccine
- Autologous GM-CSF-Secreting Lethally Irradiated Leukemia Cell Vaccine
- Autologous Heat-Shock Protein 70 Peptide Vaccine AG-858
- Autologous HNSCC DNA-transfected Semi-allogeneic Fibroblasts MRC-5 Vaccine
- Autologous IL-2-expressing B-CLL Vaccine
- Autologous Immunoglobulin Idiotype-KLH Conjugate Vaccine
- Autologous Lymphoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine
- Autologous Lymphoma Cell/Allogeneic Dendritic Cell Electrofusion Hybrid Vaccine
- Autologous Lymphoma Cell/Autologous Dendritic Cell Electrofusion Hybrid Vaccine
- Autologous Lymphoma Immunoglobulin-derived scFv-chemokine DNA Vaccine
- Autologous Melanoma Lysate-Pulsed Autologous Dendritic Cell Vaccine
- Autologous Melanoma Lysate/KLH-Pulsed Autologous Dendritic Cell Vaccine
- Autologous Melanoma Lysate/NY-ESO-1-pulsed Autologous Dendritic Cell Vaccine
- Autologous monocyte-derived mature DCs pulsed with p53, survivin and telomerase-derived peptides
- Autologous Neuroblastoma Vaccine
- Autologous NSCLC DNA-Transfected Semi-Allogeneic Fibroblasts MRC-5 Vaccine
- Autologous NSCLC Peptide-specific Dendritic Cell Vaccine
- Autologous OFA-iLRP RNA-Transfected Dendritic Cell Vaccine
- Autologous Ovarian Tumor Cell Lysate-Pulsed Dendritic Cell Vaccine
- Autologous Oxidized Ovarian Tumor Cell Lysate Vaccine
- Autologous Pluripotent ALDHbr Stem Cells ALD-451
- Autologous Prostate Cancer Antigen-expressing Dendritic Cell Vaccine BPX-101
- Autologous Renal Cell Carcinoma Tumor Lysate-Pulsed Dendritic Cell Vaccine
- Autologous Sarcoma Lysate-pulsed Dendritic Cell Vaccine
- Autologous TARP Peptide-Pulsed Dendritic Cell Vaccine
- Autologous Total Tumor mRNA and CMV-pp65-flLAMP mRNA Loaded Liposome Vaccine
- Autologous TriMix-DC Melanoma Vaccine
- Autologous tumor cell lysate vaccine
- Autologous Tumor Cell Proteoliposome Chronic Lymphocytic Leukemia Vaccine
- Autologous Tumor Cell Vaccine
- Autologous Tumor-associated Peptide Antigen-pulsed Dendritic Cell Vaccine
- Autologous, DNP-Modified Ovarian Cancer Vaccine
- Autologous-Cell Leukemia Vaccine
- Autologous-Cell Melanoma Vaccine
- B-cell lymphoma DNA vaccine VCL-1642.XXX encoding a chimeric immunoglobulin molecule onsisting of tumor-specific variable (Id) regions
- B16 melanoma DNA vaccine pCMV-hTRP-1 encoding TRP-1
- B16 melanoma DNA vaccine pSin-hTRP-1 encoding TRP-1
- B16 melanoma DNA vaccine pSin-mTRP-1
- B16 Vaccine adjuvanted by Loxoribine
- B7.1/​IL-2 Leukaemia Cell Vaccine
- Bacille Calmette Guérin for melanoma of lower extremity
- Bacillus Calmette-Guerin (BCG)
- Bacillus Calmette-Guerin (BCG), C. parvum
- Bacillus Calmette-Guerin (BCG), dinitrochlorobenzene (DNCB)
- bacillus Calmette-Guerin (MER)
- BC-819
- BCG
- BCG and chemotherapy for malignant melanoma
- BCG and Corynebacterium parvum for malignant melanoma
- BCG treatment after surgical tumor removal
- BCG, Cell Wall Skeleton
- Bcl-Xl_42-CAF09b Vaccine
- Bcl-Xs Adenovirus Vaccine
- Bcr-Abl (b2a2)-Derived Peptide Vaccine
- Bcr-Abl (b3a2)-Derived Peptide Vaccine
- Bcr-abl peptide vaccine
- Belagenpumatucel-L
- Berzofsky Ras/P53 Peptide Vaccine
- Biolistic DNA vaccination
- Bivalent Vaccine with Adjuvant OPT-821
- Brachyury-expressing Modified Vaccinia Ankara-TRICOM Vaccine
- Brain Tumor Initiating Cell Vaccine
- C29561
- Canarypox-hIL-12 Melanoma Vaccine
- Cancer DNA Vaccine encoding Endoglin Boosted with Recombinant Endoglin Protein
- Cancer DNA Vaccine encoding TEM8
- Cancer DNA Vaccine MIDGE/hNIS encoding hNIS protein
- Cancer DNA vaccine p.DOM-AH1 encoding fragment C
- Cancer DNA Vaccine pLXSHDmB7-2 encoding Cd86
- Cancer DNA Vaccine pSURV encoding Survivin
- Cancer EPCAM protein vaccine
- Cancer Her-2/neu Protein Subunit Vaccine
- Cancer recombinant vector vaccine encoding H-2Kb
- Cancer Retroviral Vector Vaccine encoding Cd40lg
- Cancer Stem Cell DC Vaccine
- Cancer Subunit DC (Tat-CEA) vaccine
- Cancer Subunit GV1001 Protein Vaccine
- Cancer Subunit NY-ESO-1 Protein Vaccine
- Cancer Vaccine using E7 protein of human papillomavirus 16 and Algammulin
- Cancer Vaccine using E7 protein of human papillomavirus 16 and Quil-A
- Cancer VEGFA protein vaccine
- Canvaxin
- CAP-2 (CEA Peptide 9-mer)
- CAP-3 (CEA Peptide 9-mer)
- CAR G36-PDL1
- Carcinoembryonic Antigen Peptide 1-6D
- Carcinoembryonic Antigen Peptide 1-6D Virus-Like Replicon Particles Vaccine
- Carcinoembryonic Antigen Peptide-1 Vaccine
- Carcinoembryonic Antigen RNA-pulsed DC Cancer Vaccine
- Carcinoma DNA vaccine pVAX/E2A
- CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
- CD133 Antigen Peptide-pulsed Autologous Dendritic Cell Vaccine
- CD80 Breast Cancer Vaccine
- CDX-1307 Vaccine
- CEA RNA-pulsed Autologous Human Cultured Dendritic Cells
- CEA/Tetanus Toxoid T Helper Epitope Fusion Protein-Expressing DNA Plasmid Vaccine
- Chimeric Ad11p/Ad3 Oncolytic Virus
- Chimeric exosomal tumor vaccine
- Class I HLA-A*0201-restricted gp100209-2M peptide vaccine
- CLL Idiotypic DNA Vaccine
- CMV pp65 Peptide-pulsed Autologous Dendritic Cell Vaccine
- CMVpp65/gB Plasmid Vaccine ASP0113
- Colorectal cancer DNA vaccine pCEA/HBsAg encoding carcinoembryonic antigen and hepatitis B surface antigen
- Contusugene ladenovec
- Corynebacterium parvum, DTIC
- CpG 7909/PF3512676
- CTP-37-DT Vaccine
- CVB4/p24(73(3))
- Cyclin B1 Peptide-pulsed Autologous Dendritic Cell Vaccine
- Cyclin B1/WT-1/CEF-Loaded DC Vaccine
- Cytokine-Induced Killer Cells
- DC/AML Fusion Vaccine
- Dendritic Cell Survivin Vaccine
- Dendritic Cell Tumor Cell Lysate Vaccine
- Dendritic Cell Tumor Peptide Vaccine
- Dendritic Cell-Autologous Lung Tumor Vaccine
- Dendritic Cell-CEA Peptide Vaccine
- Dendritic Cell-gp100-MART-1 Antigen Vaccine
- Dendritic Cell-Idiotype-Keyhole Limpet Hemocyanin Vaccine
- Dendritic Cell-MART-1 Peptide Vaccine
- Dendritic Cell-Recombinant Prostate-Specific Membrane Antigen Vaccine
- Dendritic Cell-targeting Lentiviral Vector ID-LV305
- Dendritic Cell/​Myeloma Fusion Vaccine
- Dendritic vaccine, allogeneic hematopoietic stem cells, cytotoxic lymphocytes
- Dendritic vaccine, autologous hematopoietic stem cells, cytotoxic lymphocytes
- DEPDC1/MPHOSH1 Peptide Vaccine
- Dinitrophenyl-Modified Autologous Renal Cell Carcinoma Tumor cell Vaccine
- DIPG and GMB Immunomodulatory DC Vaccine
- DLK1/EPHA2/HBB/NRP1/RGS5/TEM1 Peptide-pulsed Alpha-type-1 Polarized Dendritic Cell Vaccine
- DNA Plasmid Encoding Interleukin-12 INO-9012
- DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112
- DNA Vaccine encoding p42.3
- DNA Vaccine VB10.16
- DNA Vector pPRA-PSM Vaccine
- DNP-modified autologous vaccine
- E1M(184V) Peptide Vaccine
- EF-1 Peptide Vaccine
- EF-2 Peptide Vaccine
- EGFRvIII Peptide Vaccine
- Electrofusion DC vaccine
- electroloading of mature dendritic cells with melanoma whole tumor cell lysate
- Emepepimut-S Vaccine
- EP-2101 Vaccine
- ESAT-6-gpi DNA vaccine combined with B16F10-ESAT-6-gpi/IL-21 vaccine
- ESO-1 (161-180) Peptide Vaccine
- ESO-1 Reactive Autologous Peripheral Blood Lymphocyte Vaccine
- ESO-1:157-165(165V) Peptide Vaccine
- ESR1 peptide vaccine
- Falimarev Vaccine
- Fas-Chimera Transgene-expressing Endothelial Tumor Cell-targeting Adenovector VB-111 Vaccine
- Flagrp170
- Folate-FITC Vaccine
- Follicular lymphoma, patient-specific, soluble protein idiotype vaccine
- Fowlpox Virus Vaccine
- Fowlpox Virus Vaccine Vector
- Fowlpox-NY-ESO-1 Vaccine
- Fowlpox-PSA-TRICOM Vaccine
- FRAME-001 personalized vaccine
- FrSh61 (MEA) VHL33 Peptide Vaccine
- FVAX
- G250 Peptide Vaccine
- Gag:267-274 Peptide Vaccine
- GD2-CAR
- GD2L, GD3L, Globo H, fucosyl GM1, and N-propionylated polysialic acid KLH Conjugate Vaccine
- Genetically Engineered Allogeneic Prostate Carinoma Cells Secreting Interleukin-2 and Interferon Gamma
- GITRL RNA-transfected Autologous Dendritic Cell Vaccine
- Glioma-Associated Antigen Peptide-Pulsed Autologous Dendritic Cell Vaccine
- Glioma-associated Peptide-loaded Dendritic Cell Vaccine SL-701
- Globo H-DT Vaccine OBI-833
- Globo H-GM2-Lewis-y-MUC1-32-mer-TF(c)-Tn(c)-KLH Conjugate Vaccine
- Globo-H-GM2-Lewis-y-MUC1-32(aa)-sTn(c)-TF(c)-Tn(c)-KLH Conjugate Vaccine
- Glypican-3-derived peptide vaccine for human hepatocellular carcinoma
- GM-CSF transfected cells vaccine
- GM-CSF, IL-12 and GM-CSF+IL-12 genetically modified tumor cell vaccine
- GM-CSF-encoding Oncolytic Adenovirus CGTG-102 Vaccine
- GM-K562 cell vaccine
- GM.CD40L Cell Vaccine
- GM2/GD2/GD3 Lactone-KLH Conjugate Trivalent Vaccine
- Golnerminogene Pradenovec Vaccine
- gp100 + Mart-1 + Mart-3 Vaccine
- gp100 Adenovirus Vaccine
- gp100 and GM-CSF DNA/Gold Vaccine
- gp100 mature dendritic cell vaccine
- gp100 Protein (184V) Vaccine
- gp100 Vaccine
- gp100 Vaccinia Vaccine
- gp100-Fowlpox Vaccine
- gp100-Pulsed Peripheral Blood Mononuclear Cell Vaccine
- gp100-Reactive Autologous Peripheral Blood Lymphocyte Vaccine
- gp100/IFA Vaccine
- gp100: ES209-217(210M) Peptide Vaccine
- gp100:154-162 Peptide Vaccine
- gp100:209-217 Peptide Vaccine
- gp100:209-217(210M) peptide vaccine
- gp100:280-288 Peptide Vaccine
- gp100:280-288(288V) Peptide Vaccine
- gp96-secreting Allogeneic Bladder Cancer Cell Vaccine HS-410
- GVAX Cancer Vaccine
- GVAX Leukemia Vaccine
- GVAX Lung Cancer Vaccine
- GVAX Pancreatic Cancer Vaccine
- H3.3K27M-specific Peptide Vaccine
- hapten dinitrophenyl
- HCA587 protein vaccine
- HCV DNA Vaccine INO-8000
- HER-2-neu, CEA peptides, GM-CSF, Montanide ISA-51 vaccine
- HER2 ECD+TM Virus-like Replicon Particles Vaccine AVX901
- HER2 ICD peptide vaccine
- HER2-pulsed Autologous Type-1 Polarized Dendritic Cell Vaccine
- Hexapeptide melanoma vaccine
- HLA Neoantigen Vaccine
- HLA-A*0201-Restricted TRP2-gp100-EphA2-HER2 multipeptide Vaccine
- HLA-A*0201-Restricted URLC10-VEGFR1-VEGFR2 Multipeptide Vaccine
- HLA-A*0201-Restricted VEGFR1 Peptide Vaccine
- HLA-A*2402-Restricted VEGFR1 Peptide Vaccine
- HLA-A*2402-Restricted VEGFR1/2 Multipeptide Vaccine
- HLA-A*2404-Restricted RNF43-TOMM34-VEGFR1-VEGFR2 Multipeptide Vaccine
- HLA-A1, A2, B35-Restricted Survivin Peptides/Montanide ISA-51 Vaccine
- HLA-A1, HLA-A2, and CD40-Ligand Pulsed Dendritic Cell Vaccine
- HLA-A1-Binding MAGE-1/MAGE-3 Multipeptide-Pulsed Autologous Dendritic Cell Vaccine
- HLA-A2, A3-Restricted FGF-5 Peptides/Montanide ISA-51 Vaccine
- HLA-A2-Binding TYR/MART-1/gp100 Multipeptide-Pulsed Autologous Dendritic Cell Vaccine
- HLA-A2-Restricted Synthetic Glioma Antigen Peptides Vaccine
- HLA-Matched Donor Mononuclear Cell-Enriched Leukocytes Apocell Vaccine
- hMART-IT
- Hodgkin's antigens-GM-CSF-expressing cell vaccine
- Host Dendritic Cell Vaccine-001 MSSM/BIIR
- HPV 16 E6 (18-26) Peptide Vaccine
- HPV 16 E7:12-20 Peptide Vaccine
- HPV 16 E7:86-93 Peptide Vaccine
- HPV 16 L1-VLP Vaccine
- HPV 18 E6:13-21 Peptide Vaccine
- HPV 18 L1-VLP Vaccine
- HPV DNA Plasmids Therapeutic Vaccine VGX-3100
- HPV E6/E7 DNA Vaccine GX-188E
- HPV E6/E7-encoding Semliki Forest Virus Vaccine Vvax001
- HPV-11 Vaccine
- HPV-6-targeting Immunotherapeutic Vaccine INO-3106
- HPV16 E6/E7 Melanoma Vaccine
- HSP65-HER2 fusion peptide
- Hsp70 chaperone-based gel composition
- HSPPC-96
- hTERT I540/R572Y/D988Y Multipeptide Vaccine
- hTERT mRNA/Survivin Peptide-double-loaded Autologous Dendritic Cell Vaccine
- hTERT Multipeptide/Montanide ISA-51 VG/Imiquimod Vaccine GX 301
- hTERT Vaccine V934/V935
- hTERT-LAMP mRNA-loaded Autologous Dendritic Cell Vaccine GRNVAC1
- hTERT/Survivin/CMV Multipeptide Vaccine
- hTERT/Survivin/Melanoma Tumor Cell-Derived mRNA-Transfected Dendritic Cell Vaccine
- human leukocyte antigen class I-modified peptides
- Human Myeloid Progenitor Cells CLT-008 Vaccine
- Human Papilloma Virus L1 Virus-Like Particle V504 Vaccine
- Human Papillomavirus 16 E7 Peptide/Padre 965.10 Vaccine
- Human Papillomavirus 16/18 L1 Virus-Like Particle/AS04 Vaccine
- Human Papillomavirus Tumor Antigen Vaccine
- Human Papillomavirus Vaccine V503
- Human Prostate-Specific Membrane Antigen Plasmid DNA Vaccine
- HUVECs-OK432 vaccine
- hVEGF26-104/RFASE Peptide Vaccine
- HyperAcute - Breast cancer vaccine
- HyperAcute-Melanoma Vaccine
- HyperAcute-Prostate Cancer Vaccine
- ICT-121 Dendritic Cell Vaccine
- IDD-3
- IDH1R132H Mutation-targeting IDH1 Peptide Vaccine
- IDH1R132H-Specific Peptide Vaccine PEPIDH1M
- Idiotype-Pulsed Autologous Dendritic Cell Vaccine APC8020
- IDO peptide vaccine
- IFN/tremem
- IL-12-expressing Mesenchymal Stem Cell Vaccine GX-051
- IL-12p70
- IL-2, Peptide, and GM-CSF-in-adjuvant Melanoma Vaccine
- IL-2/Lptn Gene-Modified Allogeneic Neuroblastoma Tumor Cell Vaccine
- IL15-DC Vaccine
- IMM-101
- Immunotherapeutic GSK1572932A
- IMT-1012 Immunotherapeutic Vaccine
- Inactivated Vaccinia Virus
- Inalimarev Vaccine
- Incomplete Freund's adjuvant (IFA) alone, or a melanoma vaccine in IFA
- Indium In 111-Labeled Autologous Peripheral Blood Mononuclear Cells Vaccine
- Indium In 111-Labeled Autologous Polymorphonuclear Leukocytes Vaccine
- Indoleamine 2,3-dioxygenase Peptide Vaccine
- Interferon-gamma-expressing Adenovirus Vaccine ASN-002
- Interleukin-2 Anti-Idiotype Vaccine
- Intracel KLH Vaccine
- intralesional bacile Calmette-Guérin (BCG)
- intralesional bacile Calmette-Guérin (BCG), DTIC, vincristine
- Ipilimumab
- Ipilimumab
- ipilimumab, vemurafenib
- irradiated autologous cells
- irradiated melanoma cells plus BCG
- α-GalCer-loaded tumor-cell vaccine
- KLH and Tumor Lysate Pulsed DC Vaccine
- KLH-FITC Vaccine
- KLH-id Vaccine
- KLH-Lymphoma Ig Vaccine
- KLH-pulsed autologous dendritic cell vaccine
- KRAS-targeted mRNA vaccine
- KSA-KLH Conjugate Vaccine
- L612 HuMAb
- Lapuleucel-T Vaccine
- Large Multivalent Immunogen (LMI) vaccine
- Leukemic Apoptotic Corpse-Pulsed Autologous Dendritic Cells Vaccine
- Light-Emitting Oncolytic Vaccinia Virus GL-ONC1 Vaccine
- Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
- Liposomal MUC1/PET-lipid A Vaccine
- Live-attenuated Double-deleted Listeria monocytogenes Bacteria JNJ-64041809
- Live-attenuated Double-deleted Listeria monocytogenes Bacteria JNJ-64041809 Vaccine
- Live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 Vaccine ADU-623
- LMP-2:340-349 Peptide Vaccine
- LMP-2:419-427 Peptide Vaccine
- LMP2A-loaded conventional DC vaccine
- Long Peptide Vaccine 7
- long-peptide vaccine and mAb
- Lung metastasis DNA vaccine pCEP4-MUC1 encoding MUC1
- LY6K/VEGFR1/VEGFR2 Multipeptide Vaccine
- Lymphoma DNA vaccine VαVβVβ-FrC
- mAb PC61 and DC/tumor fusion
- MAGE-1 Vaccinia Contaminated with BVDV
- MAGE-3.A1 Peptide Vaccine
- MAGE-A1, Her-2/neu, FBP peptides ovarian cancer vaccine
- MAGE-A1/MAGE-A3/NY-ESO-1 Peptides Vaccine
- MAGE-A12:170-178
- MAGE-A3 + AS15
- MAGE-A3 Peptide Vaccine
- MAGE-A3-expressing Adenovirus Type 5 Vaccine
- MAGE-A3-genetically modified lymphocytes
- MAGE-A3/HPV 16 Peptide Vaccine
- Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
- Mammaglobin-A DNA Vaccine
- Maraba virus MG1 Vaccine
- MART-1
- MART-1 Adenovirus Vaccine
- MART-1 Fowlpox Vaccine
- MART-1 Vaccinia Vaccine
- MART-1, tyrosinase and MAGE-A6 Autologous DC Vaccine
- MART-1/gp100/Tyrosinase/MAGE-A3 Peptides-loaded Irradiated Allogeneic Plasmacytoid Dendritic Cells Vaccine
- MART-1:26-35(27L) Peptide Vaccine
- MART-1:27-35 Peptide Vaccine
- Mature dendritic cell melanoma vaccine
- MCMV-TRP2
- mCRT-vGPCR-coated whole-cell vaccine
- MDX-1379 (gp100) Melanoma Peptide Vaccine
- MDX-CTLA4 Antibody/Tyrosinase/gp100/MART-1 Melanoma Vaccine
- Melacine
- Melan-A VLP Vaccine
- Melan-A/MAGE-3.DP4 Peptide Vaccine
- Melan-A/Mart-1
- Melanoma DNA vaccine gp75 DNA encoding melanosomal membrane glycoproteins, gp75
- Melanoma DNA vaccine hTRP2 encoding TRP-2
- Melanoma DNA vaccine hugp100 encoding gp100
- Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP
- Melanoma DNA vaccine pN4a-MAGE-1-GM
- Melanoma DNA vaccine pNL3-MAGE-1-GM
- Melanoma DNA vaccine pUB-TRP-2 encoding a fusion protein linking murine ubiquitin (UB) to the N-terminus of the full-length mTRP-2
- Melanoma DNA vaccine SINCp c-muMUC18 encoding MCAM/MUC18
- Melanoma DNA vaccine TA2Mâ„¢ encoding tyrosinase peptides
- Melanoma DNA vaccine VR-S8/VR-IL2/AD-S8 encoding survivin
- Melanoma DNA vaccine VR1012/mPmel17
- Melanoma DNA vaccine xenogeneic DNA encoding murine tyrosinase
- melanoma helper peptide vaccine
- Melanoma recombinant vector vaccine rVVmTRP-1 encoding TRP-1
- Melanoma Theraccine
- Melanoma-specific Melan-A/Mart-1 peptide + virus-like nanoparticles
- Melapuldencel-T Vaccine
- MELITAC 12.1 Peptide Vaccine
- Mesothelioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
- Methanol Extraction Residue of BCG
- MG1-hDCT Vaccine
- MiHA-loaded PD-L1/L2-silenced Dendritic Cell Vaccine
- Mimotope-P10s-PADRE Peptide Vaccine
- Mixed bacterial vaccine
- Modified Vaccinia Ankara (Bavarian Nordic)-HER2 Vaccine
- Modified Vaccinia Virus Ankara Vaccine Expressing p53
- Monoclonal Antibody 105AD7 Anti-idiotype Vaccine
- Monoclonal Antibody 11D10 Anti-Idiotype Vaccine
- Monoclonal Antibody 3H1 Anti-Idiotype Vaccine
- Monoclonal Antibody 4B5 Anti-Idiotype Vaccine
- Monoclonal Antibody A1G4 Anti-Idiotype Vaccine
- Monoclonal Antibody GD2 Anti-Idiotype Vaccine
- Montanide ISA-51/Survivin Peptide Vaccine
- Mouse gp100 Plasmid DNA Vaccine
- Mouse Prostate-Specific Membrane Antigen Plasmid DNA Vaccine
- mouse/human gp10025-33 peptide plus CpG adjuvant; mouse/human gp100; mouse/human gp10025-33 peptide-pulsed DCs
- MOv-PBL Vaccine
- mRNA neoantigen tumor vaccine
- mRNA tumor antigen DC vaccine
- mRNA-based Personalized Cancer Vaccine NCI-4650
- mRNA-Derived Prostate Cancer Vaccine CV9103
- mRNA-electroporated dendritic cells encoding gp100 and tyrosinase as melanoma vaccine
- MSCV-MGMT(P140K) Vaccine
- MT-201-GBM monocyte vaccine
- MUC-1 Peptide Vaccine
- MUC-2-Globo H-KLH Conjugate Vaccine
- MUC-2-KLH Vaccine
- MUC1 Antigen/SB AS-2 Vaccine
- MUC1 Peptide-Poly-ICLC Vaccine
- MUC1-FSL-1-TT tricomponent vaccine
- MUC1-KLH Conjugate Vaccine
- MUC1-KLH Vaccine/QS21
- MUC1-targeted Peptide GO-203-2C Vaccine
- Multi-epitope Folate Receptor Alpha Peptide Vaccine
- Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
- Multi-epitope HER2 Peptide Vaccine TPIV100
- Multi-epitope melanoma peptide vaccine
- Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107
- Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
- Multiantigen Liposome Loaded Dendritic Cell Vaccine
- Multipeptide melanoma vaccine
- Multipeptide Vaccine S-588210
- Multipeptide XS15 Vaccine
- Multiple Signals loaded Dendritic Cells Vaccine
- Multivalent immunotherapeutic vaccine
- Murine TYRP2 Plasmid DNA Vaccine
- Mutant p53 Peptide Pulsed Dendritic Cell Vaccine
- Mutated neopeptide vaccine
- MVA-BN-CV301
- MVA-EBNA1/LMP2 Vaccine
- MVA-FCU1 TG4023 Vaccine
- MVA-MUC1-IL2 Vaccine
- MVA-PSA/PAP Prostate Cancer Vaccine
- MVF-HER-2(597-626)/MVF-HER-2 (266-296) Peptide Vaccine
- MVF-HER-2(628-647)-CRL 1005 vaccine
- NA-17/MAGE-3.A2/NY-ESO-1 Peptide Vaccine
- NA17.A2 Peptide Vaccine
- Natural Killer Cells ZRx101 Vaccine
- Nelipepimut-S Plus GM-CSF Vaccine
- NEO-PV-01 vaccine
- Neoantigen DNA Vaccine
- Neoantigen Peptide Vaccine
- neoantigen synthetic long peptide vaccine
- Neoantigen-loaded Autologous Dendritic Cell Vaccine
- Neuroblastoma DNA vaccine HuDsec
- Newcastle disease virus lysate
- NY-ESO-1 Peptide Vaccine
- NY-ESO-1 Plasmid DNA Cancer Vaccine
- NY-ESO-1(157-165) Peptide-pulsed Autologous Dendritic Cell Vaccine
- NY-ESO-1, MAGE-A1, and MAGE-A3 Dendritic Cell Vaccine
- NY-ESO-1/GLA-SE Vaccine ID-G305AmN
- NY-ESO-1/LAGE-1 Peptide Vaccine
- NY-ESO-1/MART-1 Peptide-pulsed Dendritic Cell Vaccine
- NY-ESO-1/PRAME/MAGE-A3/WT-1 Peptide Vaccine
- NY-ESO-1b Peptide Vaccine
- NY-ESO-B Vaccine
- OCDC and NeoDC Vaccine
- Oncolytic Adenovirus Encoding GM-CSF Vaccine
- Oncovax-ID/IL-2 Vaccine
- ONYX-015 Vaccine
- Oral Bacille Calmette-Guérin for malignant melanoma
- Oral Cancer Vaccine V3-OVA
- Oral Therapeutic Vaccine V3-X
- OVA-TEXO
- Ovapuldencel-T Vaccine
- Ovarian Cancer Peptide Vaccine
- Ovarian Cancer Stem Cell/hTERT/Survivin mRNAs-loaded Autologous Dendritic Cell Vaccine
- Ovarian Tumor Antigen-activated Autologous Dendritic Cell Vaccine
- p.DOM-WT1-126 DNA Vaccine
- p.DOM-WT1-37 DNA Vaccine
- P30-linked EphA2/CMV pp65/Survivin Peptide Vaccine P30-EPS
- P501-AS15 vaccine
- p53 Peptide Vaccine
- P53-Synthetic Long Peptides Vaccine
- PA-1-STK Ovarian Carcinoma Vaccine
- PADRE-CMV Fusion Peptide Vaccine
- Pancreatic tumor personalized neoantigen vaccine
- PAX3/FKHR Peptide Vaccine
- pcDNA3-MCC/ST
- PCLUS 3-18MN Vaccine
- PCLUS 6.1-18MN Vaccine
- pCR3.1-VS-HSP65-TP-GRP6-M2
- PD-L1 peptide vaccine
- PD-L1/IDO Peptide Vaccine IO102-103
- PEP-3-KLH Conjugate Vaccine
- PEP-CMV Vaccine
- Personal neoantigen cancer vaccine
- Personalized follicular lymphoma vaccine
- Personalized mature dendritic cell vaccine
- Personalized NeoAntigen Melanoma Vaccine
- Personalized Synthetic Long Peptide Breast Cancer Vaccine
- Pexastimogene-devacirepvec Vaccine
- PF-04948568 Vaccine
- Plasmacytoid Dendritic Cell Vaccine
- pNGVL3-hICD Vaccine
- pNGVL4a-CRT/E7(detox) DNA Vaccine
- pNGVL4a-Sig/E7(detox)/HSP70 DNA Vaccine
- Poliovirus vector expressing model antigen H2-Kb-restricted CTL epitope
- Poly Microsphere Encapsulated HER2/neu Oral Vaccine
- PolyPEPI1018 CRC Vaccine
- Polyvalent melanoma vaccine
- PR-151 Peptide Vaccine
- PR1 Leukemia Peptide Vaccine
- Primary Prostate Cancer Tissue/hTERT/Survivin mRNA-loaded Autologous Dendritic Cell Vaccine
- prime/boost DC-TRP-2 melanoma vaccine
- procarbazine, dactinomycin, velba
- Prodencel
- Prostate cancer DNA vaccine encoding PSCA
- Prostate cancer DNA vaccine hPSMAt encoding PSMA
- Prostate cancer DNA vaccine pcDNA3-STEAP encoding six-transmembrane epithelial antigen
- Prostate cancer DNA vaccine pDOM-PSMA27 encoding PSMA
- Prostate cancer DNA vaccine pmPSCA encoding PSCA
- Prostate cancer DNA vaccine PSCA-HSP encoding PSCA and HSP
- Prostate cancer DNA vaccine psig-3P-Fc encoding 3P(hPSM, hPAP, or hPSA)-Fc fusion protein
- Prostate cancer DNA vaccine pVax-PSA
- Prostate cancer DNA vaccine rPSMAt encoding PSMA
- Prostate Cancer Vaccine ONY-P1
- Prostate Tumor Antigen-activated Autologous Dendritic Cell Vaccine
- PROSTVAC-Contaminated W/ BVDV
- PSA Prostate Cancer Vaccine
- PSA RNA-Pulsed Dendritic Cell Vaccine
- PSA-OP Peptide Vaccine
- PSA-PAP/KLH-pulsed Autologous Dendritic Cell Vaccine
- PSA/IL-2/GM-CSF Vaccine
- PSA/PSMA DNA Plasmid INO-5150 Vaccine
- PSA:154-163 Peptide Vaccine
- PSA:154-163(155L) Peptide Vaccine
- PSMA/TARP Peptide Vaccine
- pTVG-HP Plasmid DNA Vaccine
- Pulmonary BCG immunotherapy for malignant melanoma
- pUMVC3-hIGFBP-2 Multi-Epitope Plasmid DNA Vaccine
- pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine
- pVAXrcPSAv53l DNA Vaccine
- Quadrivalent Human Papillomavirus (types 6, 11, 16, 18) Recombinant Vaccine
- Racotumomab Vaccine
- RAS Peptide Cancer Vaccine
- RAS Peptide Cancer Vaccine TG01
- RASVAC-C Vaccine
- RASVAC-V Vaccine
- RCAS-Akt Vaccine
- RCAS-Ras Vaccine
- Recombinant Adenovirus 5 Encoding Tumor Necrosis Factor-related Apoptosis-Inducing Ligand Vaccine
- Recombinant Adenovirus-Cre Recombinase Vaccine
- Recombinant Adenovirus-hIFN-beta Vaccine
- Recombinant Adenovirus-Interferon/Syn3 Vaccine
- Recombinant Adenovirus-L523S Vaccine
- Recombinant Adenovirus-LacZ Vaccine
- Recombinant Adenovirus-p53 SCH-58500 Vaccine
- Recombinant Anti-WT1 Immunotherapeutic GSK2302024A Vaccine
- Recombinant Colorectal cancer antigen GA733 Vaccine
- Recombinant dHER2 Vaccine
- Recombinant DNA-L523S Vaccine
- Recombinant Fowlpox GM-CSF Vaccine Adjuvant
- Recombinant Fowlpox-B7.1 Vaccine
- Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine
- Recombinant Fowlpox-gp100p209 Vaccine
- Recombinant Fowlpox-Mgp100 Vaccine
- Recombinant Fowlpox-Prostate Specific Antigen Vaccine
- Recombinant Fowlpox-PSA(L155)/TRICOM Vaccine
- Recombinant Fowlpox-TRICOM Vaccine
- Recombinant Fowlpox-Tyrosinase Vaccine
- Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
- Recombinant Human Fusion Protein L19TNFalpha Vaccine
- Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine
- Recombinant Human MUC1-Oxidized Polymannose-pulsed Autologous Dendritic Cell Vaccine
- Recombinant Human Papillomavirus Nonavalent Vaccine
- Recombinant Modified Vaccinia Ankara-5T4 Vaccine
- Recombinant NY-ESO-1 ISCOMATRIX Vaccine
- Recombinant NY-ESO-1 Protein vaccine adjuvanted with Imiquimod
- Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207
- Recombinant Vaccinia DF3/MUC1 Vaccine
- Recombinant Vaccinia PSA Vaccine
- Recombinant Vaccinia Viral Vector RO5217790 Vaccine
- Recombinant Vaccinia-CEA Vaccine
- Recombinant Vaccinia-CEA(6D)-TRICOM Vaccine
- Recombinant Vaccinia-gp100:209-217 Vaccine
- Recombinant Vaccinia-Mgp100 Vaccine
- Recombinant Vaccinia-MUC-1 Vaccine
- Recombinant Vaccinia-MUC1-B7 Vaccine
- Recombinant Vaccinia-Multiepitope Melanoma Peptides-B7.1-B7.2 Vaccine
- Recombinant Vaccinia-NY-ESO-1 Vaccine
- Recombinant Vaccinia-Prostate Specific Antigen Vaccine
- Recombinant Vaccinia-PSA/PSMA Vaccine
- Recombinant Vaccinia-TRP1 Vaccine
- Remestemcel-L Vaccine
- Renal Cell Carcinoma Peptides Vaccine IMA901
- Renal Cell Carcinoma/CD40L RNA-Transfected Autologous Dendritic Cell Vaccine AGS-003
- Renal Tumor-Reactive Autologous Peripheral Blood Lymphocyte Vaccine
- Retrovector Encoding Mutant Anti-Cyclin G1 Vaccine
- Retroviral Vector MFGS-MOv18-gamma Vaccine
- rF-MUC1(DF3)/TRICOM Vaccine
- rF-PSA/PSMA/TRICOM Vaccine
- Rilimogene-galvacirepvec Vaccine
- RIPO(H3.3)
- rMCMV-TRP2
- rMeV- SCD
- rMVTT- HPV16-E6/E7
- Sargramostim Plasmid DNA Melanoma Vaccine Adjuvant
- Sargramostim Plasmid DNA Pancreatic Tumor Cell Vaccine
- SCIB1 DNA vaccine
- secPD-L1
- short overlapping peptides and full-length recombinant protein
- Sialyl Lewis-keyhole limpet hemocyanin conjugate vaccine
- Sialyl Tn-KLH Vaccine
- Sipuleucel-T Vaccine
- smallpox vaccine
- SRL172
- STn-KLH plus Detox Vaccine
- Survivin Antigen Vaccine DPX-Survivac
- Survivin Sur1M2 Peptide Vaccine
- Survivin/p53/HER2 Antigen-loaded Autologous Dendritic Cell Vaccine
- SVN53-67/M57-KLH Peptide Vaccine
- Synchotrope TA2M Vaccine
- Synchrotope TA2M Plasmid DNA Vaccine
- Synchrovax SEM Plasmid DNA Vaccine
- Synthetic Breast Cancer Peptides-Tetanus Toxoid-Montanide ISA-51 Vaccine
- Synthetic Glioblastoma Mutated Tumor-specific Peptides Vaccine Therapy APVAC2
- Synthetic Glioblastoma Tumor-associated Peptides Vaccine Therapy APVAC1
- Synthetic hTERT DNA Vaccine INO-1400
- Synthetic Long E6/E7 Peptides Vaccine HPV-01
- Synthetic Melanoma-Associated Antigens Vaccine
- Synthetic MUC1 Peptide Vaccine
- Synthetic Peptides E-PRA And E-PSM Vaccine
- TARP 27-35 Peptide Vaccine
- TARP 29-37-9V Peptide Vaccine
- TBC-CEA-Contaminated W/ BVDV Vaccine
- Telomerase Peptide Vaccine GV1001
- Telomerase-specific Type 5 Adenovirus OBP-301 Vaccine
- Telomerase: 540-548 Peptide Vaccine
- Tergenpumatucel-L Vaccine
- Tetanus peptide melanoma vaccine
- Tetravalent RNA-lipoplex Cancer Vaccine
- TGFβ2 Antisense-GMCSF Gene Modified Autologous Tumor Cell Vaccine
- Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907
- TICE BCG
- TLR-9/GM Vaccine
- Tn(c)-KLH Conjugate Vaccine
- Total Tumor RNA-loaded Dendritic Cell Vaccine
- Transgenic Lymphocyte Immunization Vaccine
- TriAd Cancer Vaccine
- TriMixDC-MEL Vaccine
- TRP-2: 180-188 Peptide Vaccine
- TRP1(0RF3):1-9 Peptide Vaccine
- Tumor antigen-sensitized DC vaccine
- Tumor Cell Derivative Vaccine
- Tumor Lysate-pulsed Dendritic Cell Vaccine
- Tumor Lysate/KLH Pulsed Dendritic Cell Vaccine
- TVI-Brain-1
- Tyrosinase-KLH Vaccine
- tyrosinase240–251S, 368-376D Vaccine
- Unconjugated Lymphoma Ig Id Vaccine
- Unconjugated Myeloma Ig Id Vaccine
- URLC10 Peptide Vaccine
- URLC10-CDCA1-KOC1 Multipeptide Vaccine
- URLC10-TTK-KOC1-VEGFR1-VEGFR2 Multipeptide Vaccine
- UV1 Telomerase Peptide Vaccine
- vaccinia melanoma cell lysates (VMCL) Vaccine
- Vaccinia Melanoma Oncolysates (VMO) Vaccine
- Vaccinia Virus DD-CDSR Vaccine
- Vaccinia-GM-CSF Vaccine
- Vaccinia-Tyrosinase Vaccine
- VCL-CB01 Vaccine
- VEGFR-2 DNA Vaccine VXM01
- VEGFR1-1084 Peptide Vaccine
- VEGFR2-169 Peptide Vaccine
- Verpasep Caltespen Vaccine
- VHL-42: 65-76(V74G) Peptide Vaccine
- VHL-59: 116-128 Peptide Vaccine
- VHL14 Peptide Vaccine
- VHL16 Peptide Vaccine
- VHL2 (Y12M) Peptide Vaccine
- Vi Capsular Polysaccharide Typhoid Vaccine
- Viagenpumatucel-L Vaccine
- VMCL
- Von Hippel-Lindau Peptide Vaccine
- Whole tumor cell-based leukemia vaccine
- WT1 124-138 Peptide Vaccine
- WT1 126-134 Peptide Vaccine
- WT1 235-243 Peptide Vaccine
- WT1 247-261 Peptide Vaccine
- WT1 Analog Peptide Vaccine
- WT1 Peptide Vaccine OCV-501
- WT1 Peptide Vaccine WT2725
- WT1 Trio Peptide Vaccine
- WT1-A10/AS01B Immunotherapeutic GSK2130579A Vaccine
- XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410
- Xenogeneic Tyrosinase DNA Vaccine
- References
| I. General Information | ||||
|
Loading Pathogen Genes...
Loading Host Genes...
Loading Vaccines...
Loading References...

